By Jessica Mach | July 18, 2022
The change in leadership comes a year after attorneys general from several states announced a $26 billion settlement to resolve thousands of opioid lawsuits against a company subsidiary and three other firms.
By Charles Toutant | July 14, 2022
Since the District of New Jersey enacted a local rule in June 2021 mandating the disclosure of any third-party litigation funding arrangements, many such arrangements have come to light in high-profile mass tort suits in New Jersey, said Anthony Anastasio, president of the New Jersey Civil Justice Institute.
By Amanda Bronstad | June 2, 2022
Plaintiffs lawyers at Baum, Hedlund, Aristei & Goldman filed a motion to coordinate more than 30 lawsuits over Merck's Gardasil vaccine but said there could be more, citing 39 claims that went through the Vaccine Court claims process and 52 others that are pending. Michael Baum, of Baum Hedlund, called Merck's criticism a "false straw man argument."
By Colleen Murphy | May 26, 2022
The U.S. Court of Appeals for the Third Circuit ruled against a pair of pharmaceutical distributors in their constitutional claim against two private entities, finding that while the harm may be real, the claims missed a key element: a state actor.
By Charles Toutant | May 10, 2022
Since those suits were dismissed, additional information has been uncovered by plaintiffs in talc injury suits, including dozens of reports on Johnson & Johnson's talc-containing products showing the presence of asbestos and internal communications regarding development of a strategy to discredit reports showing asbestos in J&J products, the suit said.
By Charles Toutant | May 6, 2022
"Since each case registered in the Olmesartan settlement program had a common liability as well as specific facts that supported a unique damage award, such cases, including Martino's and those of the putative class of plaintiffs here, cannot ground allegations that give rise to the applicability of Rule 1:21-7(i)," Senior U.S. District Judge Robert Kugler wrote.
New Jersey Law Journal | Analysis
By James J. DeCarlo and Jose R. Vento | April 29, 2022
Be mindful of this decision when drafting patent applications. Merely mentioning a claim element once may be an insufficient written description if it is not clear that the inventor was in "possession" of the claimed subject matter.
By ALM Staff | April 27, 2022
This suit was surfaced on Law.com Radar. Read the document here.
By ALM Staff | April 6, 2022
This suit was surfaced on Law.com Radar. Read the document here.
By Charles Toutant | March 23, 2022
The ruling brings an end to roughly 500 suits in litigation that has been ongoing since 2008 and has made a stop at the U.S. Supreme Court.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Gill & Chamas, LLC seeks a Personal Injury attorney to work in their Woodbridge, NJ office. Candidate must possess the following: ...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...